SEC Tracker
Get the app
MED · XBRL financial data

Medifast financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (MED's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue from contracts with customers191,015*174,739168,558140,163119,003*115,728105,55589,40975,096*76,04476,38472,048
Cost of revenue49,646*47,44745,12034,48930,784*31,48328,91127,25022,956*24,28822,98822,008
Gross profit141,369*127,292123,438105,67488,219*84,24576,64462,15952,140*51,75653,39650,040
Research and developmentyear only———year only———year only———
Selling, general and administrative132,693*119,352131,314103,56887,510*85,50777,71066,24059,943*55,05157,72369,398
Operating income (loss)8,676*7,940(7,876)2,106709*(1,262)(1,066)(4,081)(7,803)*(3,295)(4,327)(19,358)
Interest income—1,2231,2961,333—1,3011,3691,426—1,3791,3471,508
Other income (expense)(50)*2,422(4,070)(1,861)(387)*4872,572(2)1*(25)(11)15
Income tax expense (benefit)3,767*3,269(2,496)449474*1,298395(396)11,737*181109(324)
Net income (loss)6,035*8,316(8,154)1,129801*(772)2,480(2,261)(18,119)*(2,122)(3,100)(17,511)
Earnings per share, basic USD per share0.55*0.76(0.75)0.100.07*(0.07)0.23(0.21)(1.65)*(0.19)(0.28)(1.57)
Earnings per share, diluted USD per share0.55*0.76(0.75)0.100.07*(0.07)0.22(0.21)(1.66)*(0.19)(0.28)(1.57)
Weighted average shares, basic thousands of shares10,892*10,90910,93710,93710,937*10,94810,99110,99110,993*11,00611,13511,181
Weighted average shares, diluted thousands of shares10,934*10,95810,93710,97110,986*10,94811,06010,99110,925*11,00611,13511,181

Balance sheet

CSV

Fiscal quarters (MED's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents94,44097,471108,016115,30790,92891,717101,69499,52689,30371,52971,91058,372
Short-term investments55,60158,95755,48954,64871,41672,87660,97973,98677,97097,41797,911114,162
Inventory54,59146,27339,60340,09542,42139,36430,20123,20520,22821,40321,18121,202
Prepaid and other current assets10,67011,41212,4796,6969,6399,5669,0546,8219,0666,9655,7744,028
Total current assets224,029219,584224,315224,975214,404213,523206,441207,838201,683202,630202,034201,935
Property and equipment, net51,46750,98639,92139,00337,52736,31334,59732,84631,23029,64327,98013,245
Right-of-use asset15,64514,53613,41712,29011,15510,0108,8568,3977,23212,92124,31419,498
Total assets309,908302,759293,531291,237284,213280,011269,333268,209247,973252,046260,401239,763
Total current liabilities92,30077,18775,17972,37664,16160,59846,18446,71342,96242,18441,56441,876
Lease liability, non-current16,12714,61113,06911,5199,9438,4547,1446,7906,09112,18122,46017,610
Total liabilities108,42791,79888,24883,89574,10469,05253,32853,50349,05354,36564,02459,486
Retained earnings174,649182,965174,845175,977176,782176,012178,492176,242158,269156,149153,049135,538
Total stockholders' equity201,481210,961205,283207,342210,109210,959216,005214,706198,920197,681196,377180,277
Total liabilities and equity309,908302,759293,531291,237284,213280,011269,333268,209247,973252,046260,401239,763
Common shares outstanding (cover page) thousands of shares10,89610,93710,93710,93810,93810,99110,99110,99110,99111,11911,18111,183

Cash flows

CSV

Fiscal quarters (MED's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)6,035*8,316(8,154)1,129801*(772)2,480(2,261)(18,119)*(2,122)(3,100)(17,511)
Stock-based compensation2,393*2,1712,454*606*2,132*1,9302,627*910*2,172*1,8961,818*1,850*
Depreciation and amortization3,353*3,2613,067*3,194*3,185*3,2804,045*3,452*3,465*3,4833,446*2,363*
Net cash from operating activities10,522*7,28213,069*9,072*(4,947)*3,406(3,378)*12,113*(5,278)*2601,697*3,295*
Purchases of property and equipment946*1,8411,938*1,390*2,285*1,5221,378*1,363*1,351*1,096969*427*
Net cash from investing activities(10,731)*(2,775)(2,532)*(1,782)*(19,431)*(2,054)13,357*(14,281)*(4,950)*(17,133)(1,233)*(16,822)*
Share repurchases0*00*0*0*———year only———
Dividends paid17,978*7104*1*0*1941*0*0*8783*0*
Net cash from financing activities(17,905)*(1,491)(20)*(3)*(1)*(563)(2)*0*1*(901)(83)*(11)*
Net change in cash(18,311)*3,03110,545*7,291*(24,379)*7899,977*(2,168)*(10,223)*(17,774)381*(13,538)*

Compare with peers

SIC 2090 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.

How peers are chosen
  • SIC 2090 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Fewer than three companies fall in that range, so the list adds same-SIC (2090) companies nearest in public float, each marked “added: same SIC”.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Medifast58,37272,0483,295*11.2M— 10-QSep 30, 2026
Farmer Brothers4,18688,923(786)*21.7M5.3 quarters 10-QDec 31, 2025
Utz Brandsadded: same SIC58,600371,80011,700*not reported— 10-QJun 28, 2026
Coffee Holdingadded: same SIC2,91621,6861,147*5.7M— 10-QJul 31, 2026
McCormickadded: same SIC331,1002,024,800168,100*not reported— 10-QAug 31, 2026
Top Wealth Group Holdingadded: same SIC2,387year onlyyear onlynot reported— 20-FDec 31, 2025

Not investment advice. Not affiliated with the U.S. SEC.